Lipoic Acid, Alpha
CAS 1077-28-7
Lipoic Acid, Alpha (CAS 1077-28-7) is a Phase 3 pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 93832.33127272727 nM | 55 | - |
| - | Potency | 21073.195238095235 nM | 35 | - |
| - | AC50 | 28011.590909090908 nM | 33 | - |
| - | IC50 | 27095.972857142857 nM | 13 | - |
| Acetylcholinesterase Enzyme |
IC50 | 9 | - | Homo sapiens |
| SUMO-activating enzyme Enzyme |
IC50 | 5.32 | - | Homo sapiens |
| Bifunctional protein GlmU Enzyme |
IC50 | 5.41 | - | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) |
| TAR DNA-binding protein 43 Unclassified |
IC50 | 4.7 | - | Homo sapiens |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| .ALPHA.-LIPOIC ACID | 6417 | SU | MTHSPL |
| THIOCTIC ACID | 6417 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Lipoic Acid, Alpha used for in pharmaceutical contexts?
Lipoic Acid, Alpha (CAS 1077-28-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Lipoic Acid, Alpha?
No adverse-event association or SIDER side-effect rows are rendered for Lipoic Acid, Alpha in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Lipoic Acid, Alpha also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Alpha-Lipoic Acid with EU status "permitted".
What clinical phase is Lipoic Acid, Alpha in?
Lipoic Acid, Alpha is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Lipoic Acid, Alpha?
Lipoic Acid, Alpha has 8 bioactivity rows in this page query. Rendered target entries include Acetylcholinesterase, SUMO-activating enzyme, Bifunctional protein GlmU, TAR DNA-binding protein 43.